An Australian Community-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Care Pathway for People with Type 2 Diabetes: Barriers and Considerations

The low rate of participation in the "liver health check" and liver clinic referral reflects a real-world scenario and may stem from societal under-recognition and engagement with MASLD, competing health priorities or under-appreciation of the link between liver fibrosis severity and mortality risk. Further studies need to address strategies to enhance participation in liver health assessments and determine their impact on liver-related morbidity/mortality and overall survival.

Authors

Institutions

Publication Details

Journal
Patient Preference and Adherence
Published
2024-09-01
DOI
https://doi.org/10.2147/ppa.s468705
Citations
1
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An Australian Community-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Care Pathway for People with Type 2 Diabetes: Barriers and Considerations

Elizabeth E. Powell, James P. O’Beirne, Steven McPhail, Anthony Russell et al.
1 citations
Patient Preference and Adherence
Liver Disease Diagnosis and Treatment
0.39
article

An Australian Community-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Care Pathway for People with Type 2 Diabetes: Barriers and Considerations

Elizabeth E. Powell, James P. O’Beirne, Steven McPhail, Anthony Russell, Lucy Gracen, Katharine M. Irvine, Melanie Aikebuse, Babak Sarraf, Patricia C. Valery, Suzanne T. Williams
article en
1 citations

Abstract

The low rate of participation in the "liver health check" and liver clinic referral reflects a real-world scenario and may stem from societal under-recognition and engagement with MASLD, competing health priorities or under-appreciation of the link between liver fibrosis severity and mortality risk. Further studies need to address strategies to enhance participation in liver health assessments and determine their impact on liver-related morbidity/mortality and overall survival.

Patient Preference and AdherenceVol. Volume 18
Translational Research Institute (AU), Queensland University of Technology (AU), QIMR Berghofer Medical Research Institute (AU), Royal Brisbane and Women's Hospital (AU), Princess Alexandra Hospital (AU), The Alfred Hospital (AU), Mater Research (AU), Sunshine Coast University Hospital (AU), Inala Community Health Centre (AU)
Metro South Health, Queensland Government
Good health and well-being
Openalex Percentile: Top 34%
Liver Disease Diagnosis and Treatment
0.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.